Smoking Behaviors and Prognosis in Patients With Non–Muscle-Invasive Bladder Cancer in the Be-Well Study
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.44430
Abstract: Key Points Question Are tobacco smoking and marijuana use associated with recurrence risk in patients with non–muscle-invasive bladder cancer (NMIBC)? Findings In this cohort study of 1472 adults with NMIBC, two-thirds of whom were former… read more here.
Keywords: invasive bladder; recurrence risk; patients non; risk ... See more keywords
Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5087
Abstract: To evaluate whether urine laminin‐γ2 monomer (Ln‐γ2m) offers a useful biomarker for patients with non‐muscle‐invasive bladder cancer (NMIBC). read more here.
Keywords: invasive bladder; urine laminin; non muscle; laminin monomer ... See more keywords
Preoperative systemic inflammation response index is an independent prognostic marker for BCG immunotherapy in patients with non‐muscle‐invasive bladder cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5284
Abstract: The Systemic Inflammatory Response Index (SIRI) is a novel prognostic biomarker based on peripheral blood counts of neutrophils, monocytes, and lymphocytes. Recent evidence suggests that it is associated with poor prognosis in various cancers. However,… read more here.
Keywords: invasive bladder; response index; bladder cancer; non muscle ... See more keywords
Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34502
Abstract: The VESPER trial demonstrated improved progression‐free (PFS) and (preliminarily) overall survival (OS) with six cycles of neoadjuvant dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVACx6) versus four cycles of gemcitabine and cisplatin (GCx4) before radical cystectomy… read more here.
Keywords: cancer; invasive bladder; bladder cancer; muscle invasive ... See more keywords
Poor clinical outcomes and immunoevasive contexture in interleukin‐9 abundant muscle‐invasive bladder cancer
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Cancer"
DOI: 10.1002/ijc.33237
Abstract: Chemotherapy and immunotherapy yield survival benefits for muscle‐invasive bladder cancer (MIBC) patients, in which tumor microenvironment has been found to exert crucial roles through tipping the balance between antitumor immunity and immune evasion. Our study… read more here.
Keywords: cells infiltration; bladder cancer; invasive bladder; infiltration ... See more keywords
Renal function outcomes in patients with muscle‐invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE‐01 study
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Cancer"
DOI: 10.1002/ijc.33554
Abstract: The use of pembrolizumab has been largely accepted in several advanced types of cancers. PURE 01 study (NCT02736266) enrolled consecutively 143 patients with muscle‐invasive bladder cancer who received 3 cycles of pembrolizumab 200 mg every 3 weeks… read more here.
Keywords: muscle invasive; pure study; cancer; renal function ... See more keywords
Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer
Sign Up to like & getrecommendations! Published in 2017 at "Abdominal Radiology"
DOI: 10.1007/s00261-017-1195-3
Abstract: Urothelial bladder cancer is a common malignancy requiring a multidisciplinary approach to treatment. Significant recent advances have been made in terms of the genetic and molecular characterization of bladder cancer subtypes, and novel treatment approaches… read more here.
Keywords: muscle; non muscle; bladder cancer; muscle invasive ... See more keywords
Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette–Guerin for patients with non-muscle invasive bladder cancer
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-018-2197-x
Abstract: PurposeA phase I study using two peptide vaccines derived from M phase phosphoprotein 1 (MPHOSPH1) and DEP domain containing 1 (DEPDC1) demonstrated promising results for the treatment of advanced bladder cancer. Therefore, we further tested… read more here.
Keywords: bladder cancer; patients non; bladder; muscle invasive ... See more keywords
An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer
Sign Up to like & getrecommendations! Published in 2017 at "European Radiology"
DOI: 10.1007/s00330-017-4758-3
Abstract: ObjectivesOur goal is to determine the ability of multi-parametric magnetic resonance imaging (mpMRI) to differentiate muscle invasive bladder cancer (MIBC) from non-muscle invasive bladder cancer (NMIBC).MethodsPatients underwent mpMRI before tumour resection. Four MRI sets, i.e.… read more here.
Keywords: bladder cancer; muscle; bladder; histopathology ... See more keywords
Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "European Radiology"
DOI: 10.1007/s00330-022-08696-5
Abstract: To investigate if removing DCE from the Vesical Imaging Reporting and Data System (VI-RADS) influences the diagnostic accuracy of muscle-invasive bladder cancer (MIBC). We also explored using different reference standards on the MRI diagnostic performance.… read more here.
Keywords: reference; cutoff scores; muscle invasive; bladder cancer ... See more keywords
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
Sign Up to like & getrecommendations! Published in 2018 at "World Journal of Urology"
DOI: 10.1007/s00345-018-2380-x
Abstract: ObjectivesWith the advent of novel genomic and transcriptomic technologies, new urinary biomarkers have been identified and tested for bladder cancer (BCa) surveillance. To summarize the current status of urinary biomarkers for the detection of recurrence… read more here.
Keywords: bladder cancer; muscle invasive; non muscle; cancer ... See more keywords